Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression. | J Endocrinol Invest | 2024 | 38485895 | PubTator, text mining | PubMed |
| ALKBH5 facilitates the progression of skin cutaneous melanoma via mediating ABCA1 demethylation and modulating autophagy in an m6A-dependent manner. | Int J Biol Sci | 2024 | 38481816 | PubTator, text mining | PubMed |
| ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer. | Exp Cell Res | 2024 | 38479704 | PubTator, text mining | PubMed |
| A neural m6A pathway regulates behavioral aggregation in migratory locusts. | Sci China Life Sci | 2024 | 38478296 | PubTator, text mining | PubMed |
| D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation. | Cancer Res Commun | 2024 | 38445960 | PubTator, text mining | PubMed |
| Atomic Mutagenesis of N6-Methyladenosine Reveals Distinct Recognition Modes by Human m6A Reader and Eraser Proteins. | J Am Chem Soc | 2024 | 38445613 | PubTator, text mining | PubMed |
| N6-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer. | Cancer Cell Int | 2024 | 38439072 | PubTator, text mining | PubMed |
| METTL3-Mediated LINC00475 Alternative Splicing Promotes Glioma Progression by Inducing Mitochondrial Fission. | Research (Wash D C) | 2024 | 38405130 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges. | Cell Mol Biol Lett | 2024 | 38395751 | PubTator, text mining | PubMed |
| M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells. | Cancer Biol Ther | 2024 | 38372700 | PubTator, text mining | PubMed |
| Exposure to bisphenol A affects transcriptome-wide N6-methyladenine methylation in ovarian granulosa cells. | Ecotoxicol Environ Saf | 2024 | 38354435 | PubTator, text mining | PubMed |
| Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H. | Clin Immunol | 2024 | 38331303 | PubTator, text mining | PubMed |
| Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies. | Sci Rep | 2024 | 38302672 | PubTator, text mining | PubMed |
| HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer. | Heliyon | 2024 | 38298716 | PubTator, text mining | PubMed |
| Modification patterns and metabolic characteristics of m6A regulators in digestive tract tumors. | Heliyon | 2024 | 38298699 | PubTator, text mining | PubMed |
| Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis. | J Inflamm Res | 2024 | 38298525 | PubTator, text mining | PubMed |
| Malignant peritoneal mesotheliomas of rats induced by multiwalled carbon nanotubes and amosite asbestos: transcriptome and epigenetic profiles. | Part Fibre Toxicol | 2024 | 38297314 | PubTator, text mining | PubMed |
| Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors. | Heliyon | 2024 | 38293446 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. | Cancer Cell Int | 2024 | 38291427 | PubTator, text mining | PubMed |
| Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis. | Genomics | 2024 | 38290592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=26